Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver carcinoma
|
942 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.842 | 19 | 2009 | 2020 | ||||
Breast Carcinoma
|
2793 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Malignant neoplasm of breast
|
3417 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.878 | 49 | 2001 | 2019 | ||||
Carcinoma of lung
|
1204 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Malignant neoplasm of lung
|
1142 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Primary malignant neoplasm of lung
|
981 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.921 | 38 | 2003 | 2019 | ||||
Cervix carcinoma
|
283 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.833 | 12 | 2005 | 2019 | ||||
cervical cancer
|
268 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.090 | 0.778 | 9 | 2005 | 2019 | ||||
Malignant tumor of cervix
|
245 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.090 | 0.778 | 9 | 2005 | 2019 | ||||
Malignant neoplasm of thyroid
|
103 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2012 | 2019 | ||||
Thyroid carcinoma
|
145 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2012 | 2019 | ||||
Thyroid Neoplasm
|
135 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2012 | 2019 | ||||
Multiple Myeloma
|
865 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.020 | 0.500 | 2 | 2011 | 2019 | ||||
Hepatitis C
|
347 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Hepatitis C, Chronic
|
80 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Malignant neoplasm of stomach
|
615 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Malignant Neoplasms
|
1641 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.813 | 16 | 2003 | 2018 | ||||
Stomach Carcinoma
|
652 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.750 | 16 | 2002 | 2018 | ||||
Malignant neoplasm of prostate
|
1082 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
Prostate carcinoma
|
1168 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.100 | 0.900 | 10 | 2004 | 2018 | ||||
Nasopharyngeal carcinoma
|
320 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.060 | 0.667 | 6 | 2006 | 2018 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.750 | 4 | 2008 | 2018 | ||||
Rheumatoid Arthritis
|
2387 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.040 | 0.500 | 4 | 2012 | 2018 | ||||
Carcinoma, Ovarian Epithelial
|
327 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.030 | 1.000 | 3 | 2013 | 2018 | ||||
Malignant neoplasm of ovary
|
315 | 0.441 | 0.800 | 19 | 43551574 | missense variant | T/C | snv | 0.68 | 0.71 | 0.030 | 1.000 | 3 | 2013 | 2018 |